Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 593 | 634 | 583 | 576 | 676 |
| Income taxes - deferred | 845 | N/A | N/A | 5,953 | N/A |
| Accounts receivable | -3,241 | -1,857 | -1,314 | 37,092 | -39,933 |
| Other Working Capital | -33,023 | -14,856 | -10,000 | 52,427 | 25,426 |
| Other Operating Activity | -32,814 | -34,049 | -44,280 | -86,863 | -854 |
| Operating Cash Flow | $-67,640 | $-50,128 | $-55,011 | $9,186 | $-14,686 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -211 | -57 | -169 | -1,769 | -692 |
| Purchase Of Investment | -139,167 | -26,326 | -19,514 | N/A | N/A |
| Sale Of Investment | 117,412 | 46,094 | 0 | N/A | 13,628 |
| Purchase Sale Intangibles | 0 | 0 | -363 | -31 | -4 |
| Other Investing Activity | 0 | 1,220 | 28 | 13,510 | 176 |
| Investing Cash Flow | $-21,966 | $20,930 | $-20,019 | $11,709 | $13,108 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -222 | -230 | -285 | -548 |
| Common Stock Issued | 142,087 | 32,267 | 52,328 | 41,733 | 21,574 |
| Financing Cash Flow | $142,087 | $32,045 | $52,098 | $41,449 | $21,026 |
| Exchange Rate Effect | 60 | -3,847 | 276 | -142 | -458 |
| Beginning Cash Position | 68,789 | 69,830 | 88,994 | 37,046 | 18,419 |
| End Cash Position | 121,330 | 68,830 | 66,338 | 99,248 | 37,408 |
| Net Cash Flow | $52,481 | $2,847 | $-22,932 | $62,344 | $19,448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,640 | -50,128 | -55,011 | 9,186 | -14,686 |
| Capital Expenditure | -211 | -57 | -532 | -1,800 | -700 |
| Free Cash Flow | -67,851 | -50,185 | -55,543 | 7,385 | -15,386 |